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ABSTRACT
Background
Developmental exposure to polychlorinated biphenyls (PCBs) has been implicated as a
possible cause of deficient immune function in children. This study was designed to assess
whether prenatal and postnatal exposure to PCBs impacts on antibody response to childhood
immunizations.
Methods and Findings
Two birth cohorts were formed in the Faroe Islands, where exposures vary widely, because
traditional diets may include whale blubber contaminated with PCBs. Prenatal exposure was
determined from maternal concentrations of PCBs in pregnancy serum and milk. Following
routine childhood vaccinations against tetanus and diphtheria, 119 children were examined at
18 mo and 129 children at 7 y of age, and their serum samples were analyzed for tetanus and
diphtheria toxoid antibodies and for PCBs. The antibody response to diphtheria toxoid
decreased at age 18 mo by 24.4% (95% confidence interval [CI], 1.63–41.9; p ¼ 0.04) for each
doubling of the cumulative PCB exposure at the time of examination. The diphtheria response
was lower at age 7 y and was not associated with the exposure. However, the tetanus toxoid
antibody response was affected mainly at age 7 y, decreasing by 16.5% (95% CI, 1.51–29.3; p¼
0.03) for each doubling of the prenatal exposure. Structural equation analysis showed that the
early postnatal exposure was the most important predictor of a decreased vaccination
response.
Conclusions
Increased perinatal exposure to PCBs may adversely impact on immune responses to
childhood vaccinations. The clinical implications of insufficient antibody production emphasize
the need for prevention of immunotoxicant exposures.
The Editors’ Summary of this article follows the references.
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The response of normal children to routine prophylactic
vaccinations varies substantially. While reduced vaccination
responses are well described with regard to speciﬁc immu-
nodeﬁciency syndromes [1], the reasons for the wide variation
in healthy children’s production of speciﬁc antibodies are
poorly understood [2]. Immunotoxic effects may be elicited
by certain persistent organochlorine pollutants, such as
polychlorinated biphenyls (PCBs), as indicated by decreased
concentrations of immunoglobulins and increased frequen-
cies of childhood infections in children who had been
exposed to PCBs and related compounds by their mothers’
contaminated diets [3–5]. Most experimental evidence [6], but
not all [7], points to PCB-associated immunotoxicity being
due to effects caused by dioxin-like PCB congeners.
A relevant and feasible strategy for a quantitative evalua-
tion of the immune system of infants and small children is to
measure antibody responses to immunization with thymus-
dependent neoantigens [8]. Antibody formation to such
antigens is dependent on antigen presentation, T lymphocyte
function, and B lymphocyte function and therefore reﬂects
overall efﬁcacy of the immune system in relation to infection
[8]. Because standardized methods for antibody assessment
and extensive experience on vaccine efﬁcacy are available,
antibody responses to diphtheria toxoid and tetanus toxoid
are highly suitable for this purpose [9,10].
The Faroe Islands represents a unique setting for studies of
PCB immunotoxicity. While dioxin exposure is not increased,
average PCB exposures are up to 10-fold higher than average
levels in Northern Europe, due to the traditional habit of
eating pilot whale blubber [11]. We therefore examined
vaccination responses in two Faroese birth cohorts in relation
to developmental immunotoxicant exposure.
Methods
Birth Cohorts and Clinical Examinations
Located in the North Atlantic between Shetland and
Iceland, the Faroe Islands have a population of about
50,000. The present study includes prospective data from
two sets of healthy Faroese mother-child pairs. The protocol
was approved by the ethical review committee serving the
Faroe Islands and by the institutional review board at
Harvard School of Public Health.
In 1994–1995, a cohort of 182 births was established from
consecutive spontaneous singleton births at term [12,13].
Prenatal PCB exposure was assessed from analyses of
maternal pregnancy serum and transition milk. Major
obstetric characteristics are included in Table 1. At age 7.5
y, 146 of the cohort children completed a clinical examina-
tion, and serum samples were obtained from 134 children.
Five of these children were excluded, because the most recent
booster vaccination had occurred less than six months before
the examination. Antibody analyses were carried out on all
129 serum samples, but sufﬁcient serum for PCB analysis was
available only for 124 (group A).
During 1999–2001, an additional birth cohort was formed
using similar criteria (Table 1). A subsample (group B) of this
cohort was recruited from among 279 births from a 12-mo
period. Within this group, 119 children had been vaccinated
in close accordance with the recommended schedule, and
blood samples were taken from them at age 18 mo (sufﬁcient
serum for PCB analysis was available from 116 of these
children).
Exposure levels were documented from analysis of major,
persistent PCB congeners. Samples from both cohort groups
included maternal serum obtained at the last antenatal
examination in the 34th week of pregnancy, transition milk,
and serum from the child at the time of the clinical
Table 1. Characteristics of Two Faroese Birth Cohorts Examined at Ages 7.5 y and 18 mo
Variable Group A
a Group B
a
Maternal age at parturition, y
b 28.8 (5.5) 29.7 (5.2)
Previous births (none/one/at least two), % 28.7/30.2/41.1 20.8/35.2/44.0
Smoking during pregnancy (no/yes), % 71.3/28.7 70.4/29.6
Alcohol consumption during pregnancy (never/ever), % 86.0/14.0 68.0/32.0
Gestational age, wk
b 39.6 (1.2) 39.5 (1.3)
Birth weight, g
b 3,681 (472) 3,690 (487)
Total duration of breastfeeding, mo
b 7.9 (5.1) 8.9 (4.9)
Maternal serum PCB concentration, lg/g lipid
c,d 1.22 (0.70–2.10) 1.28 (0.83–2.15)
Milk PCB concentration, lg/g lipid
c,d 1.60 (0.87–2.78) 1.35 (0.84–2.48)
Cord blood mercury concentration, lg/l
c 22.1 (13.3–41.2) 10.6 (6.0–16.3)
Age at 12-mo vaccination, mo
b 16.7 (3.3) 13.1 (1.5)
Age at 18-mo examination, mo
b n.a. 18.1 (1.3)
Age at 5-y vaccination, y
b 5.3 (0.6) n.a.
Age at 7.5-y examination, mo
b 7.5 (0.1) n.a.
Serum anti-tetanus toxoid antibody concentration, IU/ml
c 3.52 (1.90–7.55) 2.07 (0.89–4.61)
Serum anti-diphtheria toxoid antibody concentration, IU/ml
c 0.26 (0.13–0.63) 0.97 (0.37–2.60)
Serum PCB concentration, lg/g lipid
c 1.29 (0.45–1.54) 1.16 (0.66–2.07)
aGroup A consisted of 129 children who were examined at age 7.5 y; group B consisted of 119 children who were examined at age 18 mo.
bData are given as mean (standard deviation).
cData are given as geometric mean (interquartile range).
dPCB concentration was calculated as 2.0 3 ([CB-138] þ [CB-153] þ [CB-180]).
n.a., not applicable.
DOI: 10.1371/journal.pmed.0030311.t001
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Childhood Vaccination Response and PCBsexamination (i.e., at age 54 mo and again at age 7.5 y [group
A] or at 18 mo [group B]). PCB concentrations were expressed
in relation to lipid concentrations [12,14]. All milk analyses
were performed by the Department of Environmental Health,
State Agency for Health and Occupational Safety of
Schleswig-Holstein, Germany [14]. Serum analyses were
conducted by the National Center for Environmental Health
at the Centers for Disease Control and Prevention [15] and by
the University of Southern Denmark; excellent results were
obtained in intercalibration between these laboratories and
in round-robins organized by the German Society of Occupa-
tional Medicine.
To avoid problems with congeners not assessed in some
analyses and concentrations below the detection limit, a
simpliﬁed total PCB concentration was calculated as the sum
of congeners CB-138, CB-153, and CB-180 multiplied by 2.0
[11]. Because of the relevance of dioxin-like effects at
increased PCB exposures, the weighted sum of the three main
mono-ortho substituted congeners CB-105, CB-118, and CB-
156 was also calculated using toxicity equivalency factors to
obtain the dioxin equivalent concentration [16].
The above analyses also provided the concentrations of the
pesticide metabolite p,p9-dichlorodiphenyldichloroethylene
(p,p9-DDE). In addition, the mercury concentration was
measured in cord blood as a measure of prenatal methyl-
mercury exposure [12,13].
Vaccines and Antibody Measurements
All infants were vaccinated according to the ofﬁcial Danish/
Faroese vaccination program, but the schedule was changed
between examinations of the two cohorts (Figure 1). Tetanus
toxoid and diphtheria toxoid, both classical protein antigens
that depend on T helper cells for both primary and recall
antibody responses [17], were included in routine childhood
vaccinations at age 5, 6, and 15 months (group A), and 3, 5, 12
months (group B). Group A had later received a booster
vaccination at 5 y. The immunization was performed with
toxoids from Statens Serum Institut (SSI, Copenhagen,
Denmark); vaccines were preserved with aluminum oxide
hydrate, and none of the vaccines contained mercury-based
preservatives. Children from each of the study groups A and
B received the same vaccine doses. The study outcome
variables were the serum-speciﬁc antibody concentrations
measured by SSI using enzyme-linked immunosorbent assay
calibrated with international standard antitoxins and internal
standards.
Data Analysis
Effects of PCB exposure on antibody concentrations were
ﬁrst determined using standard regression techniques. Anti-
body concentrations were log-transformed to obtain nor-
mally distributed residuals with a homogeneous variance.
Models included sex, age, birth weight, maternal smoking
during pregnancy, and time from last vaccination (log-
transformed), as obligatory covariates. PCB exposure param-
eters were entered into the model, one at a time, after
logarithmic transformation. Because of the logarithmic
transformations, the effects could be expressed as the relative
change (in percent) of the outcome variables per doubling of
the exposure. Residual plots were used to assess the model ﬁt,
and regression results were also compared with the estimated
dose-response functions from generalized additive models
[18].
Exposure-related effects were then estimated in structural
equation models with latent variables [19,20]. In these models,
the observed PCB concentrations were considered manifes-
tations of a latent true exposure, which, in turn, was assumed
to affect each of the two antibody concentration outcomes.
The latent exposure variable was assumed to depend on
maternal blubber intake (dietary questionnaire response),
Figure 1. Events in Prospective Follow-Up of Two Birth Cohorts
DOI: 10.1371/journal.pmed.0030311.g001
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Childhood Vaccination Response and PCBsand covariates were allowed to correlate with the latent
exposure and the outcome. Unlike standard regression
techniques, this approach takes into account measurement
error in the exposure variables. In addition, a more powerful
analysis is obtained, because information from different
exposure markers is pooled. We ﬁrst analyzed the effects of
prenatal and postnatal exposures separately. Thus, all
markers of prenatal exposures were considered error-prone
indicators of the same latent exposure variable for exposures
to PCB or the weighted mono-ortho congeners. All prenatal
PCB exposure data were then joined into a single latent
variable. A similar model was then used to determine the
effect of postnatal exposures. Finally, we developed a model
that allowed both these latent exposure variables to affect
each outcome, with prenatal exposure at the same time as a
determinant of the postnatal concentration.
We calculated the benchmark dose as the PCB exposure
that increased the risk of an abnormal response from the
anticipated 5%–10%. To take the statistical uncertainty into
account, the lower 95% conﬁdence limit of the benchmark
dose was then calculated, in accordance with previously
established procedures [21,22].
Results
As previously observed [11,12], milk and serum concen-
trations of PCB congeners ranged over two orders of
magnitude (Table 1) and were strongly associated with one
another and also with p,p9-DDE (r ¼ 0.88 and 0.91 for
logarithmically transformed DDE and PCB in maternal serum
from groups A and B, respectively). Also, the lipid-based
concentrations in milk and pregnancy serum were similar.
However, indicators of prenatal PCB exposure (maternal
serum and milk) correlated less clearly with postnatal
exposures (child serum). In addition, the correlation of PCB
in maternal serum with mercury in cord blood was far from
close (r ¼ 0.41 and 0.32 for logarithmically transformed PCB
and mercury concentrations in groups A and B, respectively).
Antibody concentrations varied widely, and the correla-
tions between tetanus and diphtheria antibody concentra-
tions were not close (r¼0.48 at age 18 mo; r¼0.38 at age 7 y,
after logarithmic transformation). The time since the most
recent vaccination inﬂuenced antibody concentrations only
at age 18 mo (Table 2).
At age 18 mo, the participants from group B showed
negative correlation coefﬁcients between prenatal PCB
exposure and antibody concentrations, especially for the
diphtheria toxoid (Figure 2; Table 3), where a doubling of the
exposure resulted in a decrease by 20% in the antibody
response. The PCB and the weighted mono-ortho PCB
congeners showed similar effects on the antibody concen-
trations. At age 7 y group A children showed a negative effect
of the prenatal PCB exposure on the tetanus toxoid antibody
concentration (Figure 2; Table 3). Effects of postnatal
exposures were similar. Because of the close association with
PCBs that would not allow meaningful separation of the
effects, p,p9-DDE was left out of the detailed analysis. Mercury
was generally poorly associated with the antibody concen-
trations, with only one p-value below 0.3 (diphtheria in group
B; p ¼ 0.09). The PCB effects changed only minimally after
adjustment for mercury.
Most children had antibody concentrations well within the
range assumed to provide protection against diphtheria and
tetanus. Still, two years after the booster vaccination, 26 of
the group A children (21%; 95% conﬁdence interval [CI],
14%–28%) had diphtheria toxoid antibody concentrations
below the limit for long-term protection (  0.1 IU/ml).
In the structural equation model, the antibody response to
diphtheria toxoid at 18 mo of age decreased by 24.4% (95%
CI, 1.63%–41.9%) for a doubling of the combined prenatal
PCB exposure variable (Table 3). However, the antibody
concentrations were signiﬁcantly affected by both prenatal
and postnatal exposure. While the latter is, to a large extent, a
product of the former, we found that postnatal exposure in
group B was statistically signiﬁcant at a constant prenatal
exposure level, while the opposite was not the case. In the 7-y
data from group A, the tetanus toxoid antibody concen-
Table 2. Concentrations of Serum-Specific Antibody against Tetanus and Diphtheria Toxoids in Relation to Possible Predictors
Parameter Category Group A
a Group B
a
Tetanus Diphtheria Tetanus Diphtheria
Mean p-Value
b Mean p-Value
b Mean p-Value
b Mean p-Value
b
Sex Boy 5.43 0.48 5.66 2.11
Girl 5.91 0.67 0.77 0.11 6.39 0.81 1.54 0.32
Time since last vaccination Short (,2 y [group A] and 3 mo [group B]) 6.41 0.52 16.8 4.55
Long (.2 y [group A] and 3 mo [group B]) 5.58 0.65 0.62 0.74 5.04 0.025 1.58 0.001
Birth weight Above 3,000 g 5.78 0.65 6.46 2.01
Below 3,000 g 3.94 0.42 0.17 0.21 2.88 0.49 1.24 0.35
Maternal smoking during pregnancy No 6.06 0.69 4.15 1.72
Yes 4.58 0.24 0.43 0.21 10.53 0.05 2.42 0.18
Maternal serum PCB Above median 4.61 0.60 5.03 1.15
Below median 7.03 0.035 0.64 0.82 6.87 0.53 2.25 0.13
Current serum PCB Above median 4.74 0.70 7.86 1.37
Below median 6.70 0.088 0.54 0.42 3.09 0.091 2.39 0.032
Antibody concentrations are listed as IU/ml.
aGroup A consisted of 129 children examined at 7 y of age; group B consisted of 119 children examined at 18 mo of age.
bReported p-value reflects the probability of the results in the event that there is no difference the categories.
DOI: 10.1371/journal.pmed.0030311.t002
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Childhood Vaccination Response and PCBstration was primarily affected by the prenatal PCB exposure
variable, with a decrease of 16.5% for each doubling of the
exposure (95% CI, 1.51%–29.3%). The width of the CIs
suggests that differences in PCB effects on tetanus and
diphtheria, and likewise the effects of PCB and weighted
mono-ortho PCBs, should be interpreted with caution.
For comparison with previous calculations [22], benchmark
dose levels were determined for the prenatal exposure in
terms of the lipid-based PCB concentration in maternal
serum after covariate adjustment. The lower 95% conﬁdence
limit for the benchmark dose for the effect on the diphtheria
antibody concentration in group B at 18 mo was 1.14 lg/g
lipid and, for the effect on the tetanus antibody concen-
tration in group A at 7 y, 2.18 lg/g lipid. If based on the PCB
concentration in the child’s serum at the time of antibody
assessment, the two comparable BMDL results are 1.53 lg/g
lipid and 0.84 lg/g lipid.
Discussion
This study provides epidemiological evidence for an
association between exposure to environmental pollutants
and a reduction of antibody production after routine
childhood immunizations. The children examined came from
Figure 2. Dose-Effect Relationships between PCB Exposure and Antibody Response to Antigens from Routine Childhood Vaccinations
Upper graph, maternal serum concentration of PCBs plotted against serum tetanus antibody concentrations at 7 y of age. Lower graph, maternal serum
concentrations of PCBs plotted against serum diphtheria antibody concentrations, both at 18 mo of age. The broken lines indicate the 95% CIs.
DOI: 10.1371/journal.pmed.0030311.g002
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Childhood Vaccination Response and PCBspopulation-based birth cohorts and were in good health. As
anticipated [9], the antibody concentrations varied substan-
tially, while known or suspected risk factors had little impact
in comparison with PCB exposure. Although statistically
signiﬁcant associations with PCB exposure were demonstra-
ted, the CIs were wide (Figure 2). Results from the two
different birth cohorts examined at ages 18 mo and 7.5 y
showed some differences, but the tendencies seen with the
tetanus and diphtheria toxoid antibody results are in overall
agreement. Although the Faroese population has a substan-
tially increased PCB exposure [23], the results of the present
study suggest that possible adverse inﬂuences on the immune
function may well occur also at lower exposure ranges
prevalent worldwide.
The conclusions from this study must consider the
uncertainty associated with the incomplete information on
PCB exposure, which included analyses of body ﬂuid samples
widely separated in time. While the PCB body burden at birth
reﬂects the mother’s exposure, breast-feeding may transfer
substantial amounts of the mother’s accumulated PCBs via
the milk fat [24]. Thus, the postnatal PCB body burden
increases with the duration of the breast-feeding period [25].
The serum analyses available therefore present a crude
picture of the exposure proﬁle, and such imprecision is
likely to cause an underestimation of the true effect of the
exposure [26].
The Faroese population is also exposed to other seafood
contaminants [12], and effects of p,p9-DDE and PCB could not
be separated due to their close association; other potential
confounders appeared to affect the results to a minimal
degree. Regarding potentially causative PCB congeners, the
associations may be affected by differences in their persis-
tence. Thus, the persistent non-dioxin-like di-ortho PCB
congeners constitute the majority of the PCB in the samples
analyzed, and their concentrations will therefore tend to be
fairly robust. However, the immunotoxic effects could be due
to past exposures to congeners (e.g., mono-ortho PCBs or
other dioxin-like compounds), which may no longer be
present in serum in detectable concentrations, due to their
shorter half-life. In this case, the more persistent PCBs may
act as indicators of other congeners that caused the toxic
effects. The present study cannot resolve this issue.
The group B data suggest that the antibody response may
be inﬂuenced by prenatal PCB exposure, in part through its
contribution to the accumulated PCB burden during the
early postnatal period. The structural equation model
suggested that the total perinatal exposure level was the best
predictor. With regard to group A, the serum PCB concen-
tration at age 7.5 y was still affected by prenatal and
lactational transfer from the mother [15], but the current
or recent PCB levels appeared less predictive of decreased
antibody concentrations than those at birth.
Taken together, these ﬁndings point to the PCB burden in
the early postnatal period as the major determinant of
immunotoxic effects. Although this conclusion would seem
plausible [2], the serum samplings were separated in time, and
the exact timing of the greatest vulnerability cannot be
determined from these data. In this regard, two immuno-
logical issues deserve consideration.
First, the importance of the thymus for the developing
immune system is not restricted to the late gestational period,
but includes early postnatal life [27]. Thus, some speciﬁc
thymus-related T cell functions could likely be vulnerable to
PCB-mediated toxicity during early postnatal development.
Second, the priming by the ﬁrst vaccine dose before the age
of 6 mo is determined by the function of the immune system
at that time. The efﬁcacy of the priming will inﬂuence the
magnitude of antibody production upon later boosting.
Again, this consideration would support the notion that
subsequent serum antibody concentrations could be nega-
tively affected by early postnatal PCB exposure.
Although the PCB regressions for the two vaccine toxoids
were not signiﬁcantly different, the negative association of
PCB exposure with the diphtheria antibody response seemed
more pronounced than with the tetanus antibody response at
18 mo, while the reverse was the case at age 7.5 y. In addition
Table 3. Change in Serum Antibody Concentrations after Childhood Vaccinations against Diphtheria and Tetanus Associated with a
Doubling in Prenatal or Postnatal Exposure to PCBs
Category Exposure Parameter Group A
a Group B
a
Tetanus Diphtheria Tetanus Diphtheria
Change p-Value
b Change p-Value
b Change p-Value
b Change p-Value
b
Maternal serum PCB
c  16.5 0.029  3.30 0.76  2.73 0.83  20.6 0.040
Weighted mono-ortho PCB congeners
d  1.72 0.80 2.05 0.83  4.07 0.76  22.6 0.034
Milk PCB  10.5 0.18 0.07 0.99  7.05 0.53  19.0 0.037
Weighted mono-ortho PCB congeners  10.6 0.18  5.1 0.63  7.02 0.51  20.7 0.016
Child serum PCB  13.8 0.081  5.47 0.65  13.8 0.13  20.3 0.010
Weighted mono-ortho PCB congeners  13.8 0.099  4.24 0.74  5.83 0.59  17.3 0.062
Combined (structural equation model) Prenatal  16.5 0.032  4.01 0.72  8.24 0.57  24.4 0.037
Postnatal  12.3 0.12  3.61 0.69  18.9 0.036  22.1 0.026
Prenatal at constant postnatal  7.6 0.49  3.21 0.83 10.7 0.53  9.19 0.50
Postnatal at constant prenatal  11.5 0.30  0.69 0.96  20.7 0.12  23.3 0.038
Data for the first three categories were derived from multiple regression analysis.
aGroup A consisted of 129 children examined at 7 y of age; group B consisted of 119 children examined at 18 mo of age.
bReported p-value reflects the probability of the changes observed in the event that there is no association with the exposure.
cPCB concentration was calculated as 2.0 3 ([CB-138] þ [CB-153] þ [CB-180]).
dCB-105, CB-118, and CB-156 were weighted using dioxin toxicity equivalency factors.
DOI: 10.1371/journal.pmed.0030311.t003
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interpreted in light of the relative antigenicity of the toxoids,
the number of boosters received, and the stability of antibody
concentrations induced. Tetanus toxoid may be regarded as a
stronger antigen than diphtheria toxoid and is included in
the Haemophilus inﬂuenzae vaccines. The tetanus antigen
stimulation was therefore more pronounced, with average
antibody concentrations being somewhat higher at age 7.5 y
than at 18 mo. In contrast, the mean diphtheria antibody
level at age 7.5 y was only one-third of the level seen at age 18
mo, supporting the notion that this toxoid is a weaker
antigen.
At the age of 18 mo (group B) all children had reached a
protective antibody level after diphtheria vaccination. How-
ever, the percentage of children with low (, 0.1 IU/ml)
antibody levels at age 7.5 y was surprisingly high (21%), and
children with insufﬁcient antibody concentrations had a
slightly increased PCB exposure. Had the study included a
comparison group with much lower PCB exposure, the high
percentage of Faroese children with low diphtheria antibody
concentrations could perhaps have been convincingly linked
to increased PCB exposure. With regard to tetanus, the
children seemed to develop high antibody concentrations at
age 18 mo, but the maintenance of this high level through age
7.5 y appears sensitive to PCB immunotoxicity.
In establishing acceptable intake levels for toxic substances,
regulatory agencies often calculate limits based on a bench-
mark dose level and an uncertainty factor. The diphtheria
antibody response at 18 mo showed a lower 95% conﬁdence
limit for the benchmark dose of the same order of magnitude
as the one based on PCB-related neurodevelopmental deﬁcits
[22]. With a default 10-fold uncertainty factor, the exposure
limit would therefore be as low as 0.1 lg/g. Although PCB
exposure levels have tended to decrease in many parts of the
world [28], the present results suggest that further efforts are
needed to minimize this hazard.
This epidemiological study of healthy children provides
evidence of pollutant-induced reduction of antibody pro-
duction following routine childhood immunizations.
Although subtle, such immune function impairment could
become clinically important when the immune function is
challenged by other factors such as preterm birth, chronic
infection, or other disease. In addition, even slight impair-
ments could be important at a population level, e.g., with
regard to an increased prevalence of respiratory tract
infections.
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Childhood Vaccination Response and PCBsEditors’ Summary
Background. These days, mothers are as likely to worry about potential
side-effects of childhood vaccinations as about whether they completely
protect their child against infections. But healthy children vary in how
well vaccinations ‘‘take.’’ After tetanus and diphtheria vaccination, for
example, some children produce large quantities of antibodies that
protect them against these serious bacterial diseases; others make a
weaker, sometimes inadequate, immune response. What causes this
variation is unclear, but one possibility is that the developing immune
system is damaged in some babies by exposure both before birth and
after birth through breast milk to ‘‘immunotoxicants’’ such as
polychlorinated biphenyls (PCBs). These stable, man-made chemicals,
which were widely used last century as insulators in electrical equipment
and as fire retardants, accumulate and persist in the environment where
they affect animal and human health. PCB-exposed babies often have a
small thymus (the gland where immune system cells mature), make
decreased amounts of antibodies, and have more childhood infections.
Why Was This Study Done? Given these observations, could exposure
to PCBs be partly responsible for the variable immunological responses
of children to vaccination? If it is, and if environmental PCB levels remain
high, it might be necessary to adapt more intensive vaccination
programs so that all children are adequately protected against infectious
diseases. In this study, the researchers examined whether prenatal and
postnatal exposure to PCBs affects antibody responses to childhood
vaccinations
What Did the Researchers Do and Find? The researchers enrolled two
groups of children—one group born in 1994–1995, the other in 1999–
2001—living on the Faroe Islands in the North Atlantic. Here, people are
exposed to high levels of PCBs through eating contaminated whale
blubber. All the children received routine vaccinations against diphtheria
and tetanus. The bacteria that cause these illnesses do so by producing a
‘‘toxoid,’’ so a harmless quantity of these toxic proteins is injected to
stimulate a protective antibody response. For the older group, a blood
sample was taken when they were seven and half years old to test for
antibodies against diphtheria and tetanus toxoids; for the younger
group, a sample was taken at 18 months. The exposure of the children to
PCBs was assessed by measuring PCBs in their mothers’ blood during
pregnancy, in their mothers’ milk soon after birth, and in their own blood
when their antibodies were tested. The researchers found that the
antibody response to diphtheria toxoid in the younger group of children
was reduced by nearly a quarter for every doubling in their total
exposure to PCBs. The tetanus toxoid response in the older children was
reduced by a similar amount by prenatal exposure to PCBs. Although
most of the children made enough antibodies to both toxoids to provide
protection, about a fifth of the older children—mainly those with the
highest exposures to PCBs—had worryingly low levels of diphtheria
toxoid antibodies.
What Do These Findings Mean? These results reveal an association
between exposure to PCBs, particularly soon after birth, and a reduction
in immunoprotection after childhood vaccinations. It is not clear,
however, exactly how big this effect may be. This is uncertain for two
reasons. First, the estimates of how much antibody responses are
reduced by doubling PCB exposure are imprecise—for the younger
children this change in exposure might actually have very little effect on
their response to diphtheria vaccination or it could halve their response.
Second, the estimates of PCB exposures are based on only three samples
of body fluids so provide only a crude indication of exposure.
Nevertheless, these results in children exposed to high levels of PCBs
indicate that the immune function of children might also be adversely
affected by the lower levels of PCBs found elsewhere in the world.
Although the changes in immune function are subtle, they could be
clinically important, write the researchers, and might affect both the
general health of children and the degree of protection against
infectious diseases that vaccination provides. Finally, these findings
suggest that efforts must be stepped up to reduce PCB exposure levels
to protect the sensitive immune systems of young children from these
potent immunotoxicants.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0030311.
  Tox Town, a Web site available from the US National Institutes of
Health, provides an introduction to toxic chemicals and environmental
health risks
  US Agency for Toxic Substances and Disease Registry fact sheet on
PCBs
  US Environmental Protection Agency information on PCBs
  MedlinePlus encyclopedia entries on immunization tetanus vaccine,
and diphtheria vaccine
  Wikipedia pages on PCBs and vaccines (note: Wikipedia is a free online
encyclopedia that anyone can edit)
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